Skip to content

NORDPHARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

NORDPHARMA

BE 0749.928.180
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 compared with 2023filed annual accounts (NBB)
Net result for the year
€79,630
2023 · €77,576+€2,054
Equity
€494,640
2023 · €465,011+€29,630
Cash
€103,945
2023 · €84,414+€19,531
Balance sheet total
€784,352
2023 · €748,159+€36,194

Largest movements

2023 to 2024
Assets
  • Stocks and contracts -€23,745

    down €23,745 (-34.9%), from €67,942 to €44,197

  • Intangible fixed assets +€19,850

    up €19,850 (+23.4%), from €85,000 to €104,850

  • Deferred charges and accrued income +€19,666

    up €19,666 (+26.2%), from €75,016 to €94,683

  • Cash +€19,531

    up €19,531 (+23.1%), from €84,414 to €103,945

    mainly Net result for the year (+€79,630) and Other debts (+€62,608)

Equity and liabilities
  • Other debts +€62,608

    up €62,608 (+43.7%), from €143,376 to €205,984

  • Trade debts -€49,662

    down €49,662 (-87.0%), from €57,088 to €7,426

  • Profit (loss) carried forward +€29,630

    up €29,630 (+65.8%), from €45,011 to €74,640

  • Debts after one year -€13,739

    down €13,739 (-39.5%), from €34,749 to €21,010

Income statement
  • Purchases and services +€77,101

    up €77,101 (+7.7%), from €995,433 to €1.1m

  • Turnover +€67,554

    up €67,554 (+5.3%), from €1.3m to €1.4m

  • Other operating charges -€34,774

    down €34,774 (-91.4%), from €38,037 to €3,263

  • Staff costs +€27,085

    up €27,085 (+24.9%), from €108,902 to €135,987

  • Depreciation -€15,531

    down €15,531 (-29.1%), from €53,458 to €37,927

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 €77,576
Gross operating margin -€9,547
Staff costs -€27,085
Depreciation +€15,531
Write-downs -€12,500
Other operating charges +€34,774
Financial charges +€1,671
Taxes -€791
Result 2024 €79,630
raises the resultlowers the result

Derived cash bridge

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€145,179
Investment -€61,909
Financing -€63,739
Cash 2023 €84,414
Net result for the year +€79,630
Depreciation +€37,927
Stocks and contracts +€23,745
Receivables within one year +€3,241
Deferred charges and accrued income -€19,666
Trade debts -€49,662
Tax, wage and social debts +€7,357
Other debts +€62,608
Investment in fixed assets (net) -€61,909
Debts after one year -€13,739
Contributions, distributions and other -€50,000
Cash 2024 €103,945
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2023 2024 Change %
Total assets 20/58 €748,159 €784,352 +€36,194 +4.8%
Fixed assets 21/28 €447,394 €471,376 +€23,982 +5.4%
Intangible fixed assets 21 €85,000 €104,850 +€19,850 +23.4%
Tangible fixed assets 22/27 €362,394 €366,526 +€4,132 +1.1%
Land and buildings 22 €261,667 €255,000 -€6,667 -2.5%
Plant, machinery and equipment 23 €92,407 €104,280 +€11,873 +12.8%
Furniture and vehicles 24 €8,320 €7,246 -€1,074 -12.9%
Current assets 29/58 €300,765 €312,976 +€12,212 +4.1%
Stocks and contracts in progress 3 €67,942 €44,197 -€23,745 -34.9%
Stocks 30/36 €67,942 €44,197 -€23,745 -34.9%
Amounts receivable within one year 40/41 €73,392 €70,151 -€3,241 -4.4%
Trade receivables 40 €59,808 €59,577 -€232 -0.4%
Other amounts receivable 41 €13,584 €10,574 -€3,009 -22.2%
Cash at bank and in hand 54/58 €84,414 €103,945 +€19,531 +23.1%
Deferred charges and accrued income 490/1 €75,016 €94,683 +€19,666 +26.2%
Total equity and liabilities 10/49 €748,159 €784,352 +€36,194 +4.8%
Equity 10/15 €465,011 €494,640 +€29,630 +6.4%
Contributions 10/11 €420,000 €420,000 = 0.0%
Contributions outside capital 11 €420,000 - -€420,000
Other 1109/19 €420,000 - -€420,000
Profit (loss) carried forward 14 €45,011 €74,640 +€29,630 +65.8%
Amounts payable 17/49 €283,148 €289,712 +€6,564 +2.3%
Amounts payable after more than one year 17 €34,749 €21,010 -€13,739 -39.5%
Financial debts 170/4 €34,749 €21,010 -€13,739 -39.5%
Amounts payable within one year 42/48 €248,399 €268,702 +€20,303 +8.2%
Current portion of amounts payable after more than one year 42 €14,547 €14,547 = 0.0%
Trade debts 44 €57,088 €7,426 -€49,662 -87.0%
Suppliers 440/4 €57,088 €7,426 -€49,662 -87.0%
Taxes, remuneration and social security 45 €33,388 €40,745 +€7,357 +22.0%
Taxes 450/3 €14,562 €14,516 -€45 -0.3%
Remuneration and social security 454/9 €18,826 €26,228 +€7,402 +39.3%
Other amounts payable 47/48 €143,376 €205,984 +€62,608 +43.7%
Turnover 70 €1,284,880 €1,352,434 +€67,554 +5.3%
Goods, raw materials, services and sundry goods 60/61 €995,433 €1,072,534 +€77,101 +7.7%
Remuneration, social security and pensions 62 €108,902 €135,987 +€27,085 +24.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €53,458 €37,927 -€15,531 -29.1%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €12,500 +€12,500
Other operating charges 640/8 €38,037 €3,263 -€34,774 -91.4%
Gross operating margin 9900 €289,447 €279,900 -€9,547 -3.3%
Operating profit (loss) 9901 €89,050 €90,224 +€1,174 +1.3%
Financial charges 65/66B €4,080 €2,409 -€1,671 -41.0%
Recurring financial charges 65 €4,080 €2,409 -€1,671 -41.0%
Profit (loss) for the period before taxes 9903 €84,970 €87,815 +€2,845 +3.3%
Income taxes 67/77 €7,394 €8,185 +€791 +10.7%
Profit (loss) for the period 9904 €77,576 €79,630 +€2,054 +2.6%
Profit (loss) for the period to be appropriated 9905 €77,576 €79,630 +€2,054 +2.6%

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.